The Mountain Area Health Education Center (MAHEC) and the University of North Carolina Asheville (UNC Asheville) are continuing their strong partnership to protect Western North Carolina from COVID-19, this time joining forces with the Federal Emergency Management Agency (FEMA). Starting in October 2021, UNC Asheville, MAHEC and FEMA will operate a walk-in COVID-19 immunization site and booster clinic at the UNC Asheville Reuter Center located on 1 Campus View Road in Asheville.
Vaccinations will be available at the Reuter Center on weekends in October. November dates will be added if there is enough demand.
- Fridays in October: 1:00 to 8:00 p.m.
- Saturdays and Sundays in October: 9:00 a.m. – 5:00 p.m.
No appointments are required to enter the site. All three vaccines (Pfizer, Moderna, and Johnson & Johnson) will be available for those seeking their first or second dose.
According to the CDC, the following individuals should get a booster shot:
- people 65 years of age and older
- residents of long-term care settings
- people 50–64 years of age with certain underlying medical conditions
- people 18–49 years of age with certain underlying medical conditions
- people 18–64 years of age who are at increased risk for COVID-19 exposure and transmission because of their occupational or institutional setting
- people 18–64 years of age who are at increased risk for COVID-19 exposure and transmission because of their occupational or institutional setting, including if you work in a high-risk profession, meaning you come into contact with a lot of people, and you don’t know their vaccination status; for example, health care workers, first responders, teachers, food processing workers, retail and restaurant workers, and public transportation workers. The group also includes individuals who live or work in a place where many people live together; for example, homeless shelters, correctional facilities, migrant farm housing, dormitories or other group living settings in colleges or universities.
Currently, booster doses are not recommended for those who received Moderna or J&J vaccines, but may be recommended in the future after the CDC conducts a thorough review of safety and efficacy data.
Share
Permalink: